BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Staging
1668 results:

  • 1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
    Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
    World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A pictorial view on false positive findings of
    Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
    Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. prostate cancer, Version 3.2024.
    Schaeffer EM; Srinivas S; Adra N; An Y; Bitting R; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Karnes RJ; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Szmulewitz R; Teply BA; Tward J; Valicenti R; Wong JK; Snedeker J; Freedman-Cass DA
    J Natl Compr Canc Netw; 2024 Apr; 22(3):140-150. PubMed ID: 38626801
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Is Unilateral Lymphadenectomy an Option in Selected Patients with prostate cancer?
    Kassab BN; De Pablos-Rodríguez P; Ferrer ÁG; García AC; Fons AC; Aragón F; Ramón-Borja JC; Ramírez-Backhaus M
    Arch Esp Urol; 2024 Mar; 77(2):129-134. PubMed ID: 38583004
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
    Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
    BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tripedal DNA Walker as a Signal Amplifier Combined with a Potential-Resolved Multicolor Electrochemiluminescence Strategy for Ultrasensitive Detection of prostate cancer staging Indicators.
    Wang YZ; Zhang YQ; Liu Y; Li YR; Li ML; Meng GR; Mi L; Hu YH; Xu JJ
    Anal Chem; 2024 Apr; 96(15):5852-5859. PubMed ID: 38556977
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
    Kolade OU; Brink A; Ayeni AO; More S; Holness J
    Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
    Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
    BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
    Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
    BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system.
    Bennett R; Li EV; Ho AY; Aguiar JA; Neill C; Rowe SP; Patel HD; Savas H; Ross AE
    Prostate; 2024 Jun; 84(8):717-722. PubMed ID: 38450787
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [
    Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
    Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictive accuracy of boosted regression model in estimating risk of venous thromboembolism following minimally invasive radical surgery in pharmacological prophylaxis-naïve men with prostate cancer.
    Leong CH; Ranjan SR; Javed A; Alsaedi BSO; Nabi G
    World J Surg Oncol; 2024 Feb; 22(1):67. PubMed ID: 38395873
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ductal prostate cancer staging: Role of PSMA PET/CT.
    Pepe P; Pepe L; Curduman M; Pennisi M; Fraggetta F
    Arch Ital Urol Androl; 2024 Feb; 96(1):12132. PubMed ID: 38363231
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
    Singhal T; Singh P; Parida GK; Agrawal K
    Ann Nucl Med; 2024 Mar; 38(3):176-187. PubMed ID: 38340144
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intraductal prostate cancer Affinity for Lymphatic-Predominant Metastases Through
    Bernardino R; Sayyid RK; Lajkosz K; Al-Daqqaq Z; Tiwari R; Cockburn J; Leão R; Metser U; Berlin A; van der Kwast T; Fleshner NE
    J Urol; 2024 Apr; 211(4):586-593. PubMed ID: 38299501
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to prostate cancer Imaging : Complementary Role in PSMA-Negative Cases.
    Ergül N; Çermik TF; Alçın G; Arslan E; Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Baykal Koca S; Türkay R; Yücetaş U
    Clin Nucl Med; 2024 Mar; 49(3):e105-e110. PubMed ID: 38271254
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-staging System.
    Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
    Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combination of [
    Kim J; Lee S; Kim D; Kim HJ; Oh KT; Kim SJ; Choi YD; Giesel FL; Kopka K; Hoepping A; Lee M; Yun M
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1763-1772. PubMed ID: 38200396
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized prostate cancer.
    Deville C; Kamran SC; Morgan SC; Yamoah K; Vapiwala N
    Pract Radiat Oncol; 2024; 14(1):47-56. PubMed ID: 38182303
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study.
    Fei X; Du X; Wang J; Liu J; Gong Y; Zhao Z; Cao Z; Fu Q; Zhu Y; Dong L; Dong B; Pan J; Sun W; Xie S; Xue W
    Int J Surg; 2024 Mar; 110(3):1450-1462. PubMed ID: 38181121
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 84.